Cite
US National Institutes of Health Prioritization of SARS-CoV-2 Variants
MLA
Turner, Sam, et al. “US National Institutes of Health Prioritization of SARS-CoV-2 Variants.” Emerging Infectious Diseases, vol. 29, no. 5, May 2023, p. e1. EBSCOhost, https://doi.org/10.3201/eid2905.221646.
APA
Turner, S., Alisoltani, A., Bratt, D., Cohen-Lavi, L., Dearlove, B. L., Drosten, C., Fischer, W. M., Fouchier, R. A. M., Gonzalez-Reiche, A. S., Jaroszewski, L., Khalil, Z., LeGresley, E., Johnson, M., Jones, T. C., Muhlemann, B., O’Connor, D., Sedova, M., Shukla, M., Theiler, J., … Smith, D. J. (2023). US National Institutes of Health Prioritization of SARS-CoV-2 Variants. Emerging Infectious Diseases, 29(5), e1. https://doi.org/10.3201/eid2905.221646
Chicago
Turner, Sam, Arghavan Alisoltani, Debbie Bratt, Liel Cohen-Lavi, Bethany L. Dearlove, Christian Drosten, Will M. Fischer, et al. 2023. “US National Institutes of Health Prioritization of SARS-CoV-2 Variants.” Emerging Infectious Diseases 29 (5): e1. doi:10.3201/eid2905.221646.